A group of high-likelihood Alzheimer’s disease patients had higher mIns and higher postmortem GFAP staining than low-likelihood controls, although in the combined sample GFAP and mIns levels did not reach a statistical correlation (Murray et al., 2014). The gene discussed is GFAP; the disease is Alzheimer disease.